Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Other Working Capital Changes data on file, last reported at -$522000.0 in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$522000.0, down 98.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$807000.0 (down 778.15% YoY), and the FY2025 annual result was -$548000.0, down 226.56% from the prior year.
• Other Working Capital Changes eased to -$522000.0 in Q1 2026 per CRBU's latest filing, from $1.2 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $5.6 million in Q2 2023 and troughed at -$16.1 million in Q4 2023.
• A 5-year average of -$1.0 million and a median of -$161000.0 in 2022 frame the typical range for Other Working Capital Changes.
• On a YoY basis, Other Working Capital Changes climbed as much as 3549.69% in 2023 and fell as far as 1433.94% in 2023.
• A 5-year view of Other Working Capital Changes shows it stood at -$1.0 million in 2022, then slumped by 1433.94% to -$16.1 million in 2023, then surged by 105.59% to $900000.0 in 2024, then soared by 32.56% to $1.2 million in 2025, then plunged by 143.76% to -$522000.0 in 2026.
• Business Quant data shows CRBU's Other Working Capital Changes at -$522000.0 in Q1 2026, $1.2 million in Q4 2025, and $155000.0 in Q3 2025.